glp-1 drugs for parkinson's disease Are diabetes like Ozempic coming disease? — Parkinson Secrets GLP-1 receptor agonists in Parkinson's
Description
While generally safe and effective, long-term cardiovascular and immune implications remain understudied and thus represent major unanswered concerns
[DOI] [PubMed] [Google Scholar] 461.Scrocchi L.A., Marshall B.A., Cook S.M., Brubaker P.L., Drucker D.J
GLP-1 Receptor Agonists Obesity Drugs Market Insight The U.S
Approval timeline is estimated for late 2026 or 2027, making it unavailable for immediate use but worth watching closely
For example, if you typically inject in your abdomen, consider switching to your thigh
